Alnylam Pharmaceuticals Inc (ALNY)
269.17
-11.79
(-4.20%)
USD |
NASDAQ |
Mar 26, 16:00
269.17
0.00 (0.00%)
After-Hours: 18:55
Alnylam Pharmaceuticals PE Ratio
View 4,000+ Financial Data Types:
Add
Browse
PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Pfizer Inc | 17.86 |
| Biomarin Pharmaceutical Inc | 32.50 |
| BridgeBio Pharma Inc | -- |
| Regeneron Pharmaceuticals Inc | 16.71 |
| Vertex Pharmaceuticals Inc | -- |
PE Ratio Related Metrics
| PS Ratio | 15.28 |
| Price to Book Value | 519.41 |
| Price | 269.17 |
| Earnings Yield | -0.81% |
| Market Cap | 34.85B |